Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1990 Aug;47(2):266–274.

Effective testing of gene-disease associations.

M Swift 1, L L Kupper 1, C L Chase 1
PMCID: PMC1683710  PMID: 2378351

Abstract

We propose a method for testing any hypothesized association between a candidate allele, for which there is a specific laboratory test, and a common chronic disease. Families in which this allele is segregating are identified through index individuals who are homozygous or heterozygous for the allele. The sample consists of the subset of identified families who also have at least one member with the common disease of interest. For each independent family in this subset, select one person with the disease and determine if he or she is heterozygous for the allele. The observed proportion of heterozygotes in this sample is compared to the proportion expected on the basis of each diseased relative's null probability of being heterozygous for the allele; this null probability depends only on the relative's relationship to the index individual and the population allele frequency. We provide these null probabilities, develop appropriate inference procedures, discuss sample size requirements, and compare this method to a standard case-control design. Results using this method are unlikely to be influenced by confounders, systematic bias, or genetic heterogeneity.

Full text

PDF
266

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burmer G. C., Rabinovitch P. S., Loeb L. A. Analysis of c-Ki-ras mutations in human colon carcinoma by cell sorting, polymerase chain reaction, and DNA sequencing. Cancer Res. 1989 Apr 15;49(8):2141–2146. [PubMed] [Google Scholar]
  2. Campbell M. A., Elston R. C. Relatives of probands: models for preliminary genetic analysis. Ann Hum Genet. 1971 Oct;35(2):225–236. doi: 10.1111/j.1469-1809.1956.tb01395.x. [DOI] [PubMed] [Google Scholar]
  3. Cooper D. N., Clayton J. F. DNA polymorphism and the study of disease associations. Hum Genet. 1988 Apr;78(4):299–312. doi: 10.1007/BF00291724. [DOI] [PubMed] [Google Scholar]
  4. Dubeau L., Chandler L. A., Gralow J. R., Nichols P. W., Jones P. A. Southern blot analysis of DNA extracted from formalin-fixed pathology specimens. Cancer Res. 1986 Jun;46(6):2964–2969. [PubMed] [Google Scholar]
  5. Ebringer R. W. HLA-B27 and the link with rheumatic diseases: recent developments. Clin Sci (Lond) 1980 Dec;59(6):405–410. doi: 10.1042/cs0590405. [DOI] [PubMed] [Google Scholar]
  6. Gatti R. A., Berkel I., Boder E., Braedt G., Charmley P., Concannon P., Ersoy F., Foroud T., Jaspers N. G., Lange K. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature. 1988 Dec 8;336(6199):577–580. doi: 10.1038/336577a0. [DOI] [PubMed] [Google Scholar]
  7. Gerhard D. S., Dracopoli N. C., Bale S. J., Houghton A. N., Watkins P., Payne C. E., Greene M. H., Housman D. E. Evidence against Ha-ras-1 involvement in sporadic and familial melanoma. Nature. 1987 Jan 1;325(6099):73–75. doi: 10.1038/325073a0. [DOI] [PubMed] [Google Scholar]
  8. Goldin L. R., Gershon E. S. Power of the affected-sib-pair method for heterogeneous disorders. Genet Epidemiol. 1988;5(1):35–42. doi: 10.1002/gepi.1370050104. [DOI] [PubMed] [Google Scholar]
  9. Hall J. M., Huey B., Morrow J., Newman B., Lee M., Jones E., Carter C., Buehring G. C., King M. C. Rare HRAS alleles and susceptibility to human breast cancer. Genomics. 1990 Jan;6(1):188–191. doi: 10.1016/0888-7543(90)90466-8. [DOI] [PubMed] [Google Scholar]
  10. Hutchison D. C. Natural history of alpha-1-protease inhibitor deficiency. Am J Med. 1988 Jun 24;84(6A):3–12. doi: 10.1016/0002-9343(88)90153-2. [DOI] [PubMed] [Google Scholar]
  11. Krontiris T. G., DiMartino N. A., Colb M., Parkinson D. R. Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients. 1985 Jan 31-Feb 6Nature. 313(6001):369–374. doi: 10.1038/313369a0. [DOI] [PubMed] [Google Scholar]
  12. Lander E. S., Botstein D. Strategies for studying heterogeneous genetic traits in humans by using a linkage map of restriction fragment length polymorphisms. Proc Natl Acad Sci U S A. 1986 Oct;83(19):7353–7357. doi: 10.1073/pnas.83.19.7353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Schiliro G., Li Volti S., Marino S., Dibenedetto S. P., Samperi P., Testa R., Mollica F. Increase with age in the prevalence of beta-thalassemia trait among Sicilians. N Engl J Med. 1989 Sep 14;321(11):762–762. doi: 10.1056/NEJM198909143211115. [DOI] [PubMed] [Google Scholar]
  14. Strong L. C., Herson J., Haas C., Elder K., Chakraborty R., Weiss K. M., Majumder P. Cancer mortality in relatives of retinoblastoma patients. J Natl Cancer Inst. 1984 Aug;73(2):303–311. doi: 10.1093/jnci/73.2.303. [DOI] [PubMed] [Google Scholar]
  15. Swift M., Chase C. L., Morrell D. Cancer predisposition of ataxia-telangiectasia heterozygotes. Cancer Genet Cytogenet. 1990 May;46(1):21–27. doi: 10.1016/0165-4608(90)90004-t. [DOI] [PubMed] [Google Scholar]
  16. Swift M., Reitnauer P. J., Morrell D., Chase C. L. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med. 1987 May 21;316(21):1289–1294. doi: 10.1056/NEJM198705213162101. [DOI] [PubMed] [Google Scholar]
  17. WOOLF B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955 Jun;19(4):251–253. doi: 10.1111/j.1469-1809.1955.tb01348.x. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES